Grantham Mayo Van Otterloo & Co. LLC boosted its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 49.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,276 shares of the technology company's stock after purchasing an additional 4,730 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC's holdings in Amdocs were worth $1,215,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of the stock. Pzena Investment Management LLC boosted its holdings in shares of Amdocs by 4.3% in the 4th quarter. Pzena Investment Management LLC now owns 6,634,549 shares of the technology company's stock worth $564,866,000 after purchasing an additional 270,810 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Amdocs by 2.8% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 3,263,591 shares of the technology company's stock worth $274,681,000 after buying an additional 87,801 shares in the last quarter. Vanguard Group Inc. grew its position in Amdocs by 16.1% during the fourth quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock valued at $261,756,000 after acquiring an additional 426,035 shares during the last quarter. Wellington Management Group LLP grew its position in Amdocs by 25.4% during the fourth quarter. Wellington Management Group LLP now owns 2,680,422 shares of the technology company's stock valued at $228,211,000 after acquiring an additional 543,490 shares during the last quarter. Finally, Pacer Advisors Inc. raised its stake in shares of Amdocs by 7.4% during the fourth quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company's stock worth $154,587,000 after acquiring an additional 125,654 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $101.20.
View Our Latest Stock Report on Amdocs
Amdocs Trading Up 1.2 %
DOX traded up $0.97 during trading on Friday, hitting $83.18. 739,768 shares of the stock traded hands, compared to its average volume of 701,930. The firm has a market capitalization of $9.39 billion, a P/E ratio of 19.30, a price-to-earnings-growth ratio of 1.47 and a beta of 0.59. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $93.34. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. The firm has a 50-day moving average of $87.67 and a 200 day moving average of $87.26.
Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Equities research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date of this dividend is Monday, March 31st. This is an increase from Amdocs's previous quarterly dividend of $0.48. Amdocs's dividend payout ratio is currently 48.72%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
